These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23992993)

  • 1. Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells.
    Ohlsson L; Exley C; Darabi A; Sandén E; Siesjö P; Eriksson H
    J Inorg Biochem; 2013 Nov; 128():229-36. PubMed ID: 23992993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Al adjuvants can be tracked in viable cells by lumogallion staining.
    Mile I; Svensson A; Darabi A; Mold M; Siesjö P; Eriksson H
    J Immunol Methods; 2015 Jul; 422():87-94. PubMed ID: 25896212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.
    Mold M; Shardlow E; Exley C
    Sci Rep; 2016 Aug; 6():31578. PubMed ID: 27515230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminium adjuvants in vaccines - A way to modulate the immune response.
    Danielsson R; Eriksson H
    Semin Cell Dev Biol; 2021 Jul; 115():3-9. PubMed ID: 33423930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants.
    Svensson A; Sandberg T; Siesjö P; Eriksson H
    Immunol Res; 2017 Dec; 65(6):1164-1175. PubMed ID: 29181774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes.
    Česen MH; Repnik U; Turk V; Turk B
    Cell Death Dis; 2013 Oct; 4(10):e818. PubMed ID: 24091661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.
    Wilson NS; Duewell P; Yang B; Li Y; Marsters S; Koernig S; Latz E; Maraskovsky E; Morelli AB; Schnurr M; Ashkenazi A
    J Immunol; 2014 Apr; 192(7):3259-68. PubMed ID: 24610009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles.
    Sun B; Ji Z; Liao YP; Wang M; Wang X; Dong J; Chang CH; Li R; Zhang H; Nel AE; Xia T
    ACS Nano; 2013 Dec; 7(12):10834-49. PubMed ID: 24261790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
    Eisenbarth SC; Colegio OR; O'Connor W; Sutterwala FS; Flavell RA
    Nature; 2008 Jun; 453(7198):1122-6. PubMed ID: 18496530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.
    Ruwona TB; Xu H; Li X; Taylor AN; Shi YC; Cui Z
    Vaccine; 2016 Jun; 34(27):3059-3067. PubMed ID: 27155490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nickel induces interleukin-1β secretion via the NLRP3-ASC-caspase-1 pathway.
    Li X; Zhong F
    Inflammation; 2014 Apr; 37(2):457-66. PubMed ID: 24158569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of aluminium-containing adjuvants.
    White JL; Hem SL
    Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alum triggers infiltration of human neutrophils ex vivo and causes lysosomal destabilization and mitochondrial membrane potential-dependent NET-formation.
    Reithofer M; Karacs J; Strobl J; Kitzmüller C; Polak D; Seif K; Kamalov M; Becker CFW; Greiner G; Schmetterer K; Stary G; Bohle B; Jahn-Schmid B
    FASEB J; 2020 Oct; 34(10):14024-14041. PubMed ID: 32860638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive cellular response to aluminum based adjuvants.
    Nies I; Hidalgo K; Bondy SC; Campbell A
    Environ Toxicol Pharmacol; 2020 Aug; 78():103404. PubMed ID: 32388105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in mice.
    Freiberger SN; Leuthard DS; Duda A; Contassot E; Thallmair M; Kündig TM; Johansen P
    Eur J Pharm Sci; 2018 Mar; 115():362-368. PubMed ID: 29410031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation.
    Heid ME; Keyel PA; Kamga C; Shiva S; Watkins SC; Salter RD
    J Immunol; 2013 Nov; 191(10):5230-8. PubMed ID: 24089192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells.
    Abdalla MY; Ahmad IM; Switzer B; Britigan BE
    Redox Biol; 2015; 4():328-39. PubMed ID: 25638774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aluminum as an adjuvant in vaccines and post-vaccine reactions].
    Fiejka M; Aleksandrowicz J
    Rocz Panstw Zakl Hig; 1993; 44(1):73-80. PubMed ID: 8235346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidification of phagosomes and degradation of rod outer segments in rat retinal pigment epithelium.
    Deguchi J; Yamamoto A; Yoshimori T; Sugasawa K; Moriyama Y; Futai M; Suzuki T; Kato K; Uyama M; Tashiro Y
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):568-79. PubMed ID: 8113008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular chloride channel protein CLIC1 regulates macrophage function through modulation of phagosomal acidification.
    Jiang L; Salao K; Li H; Rybicka JM; Yates RM; Luo XW; Shi XX; Kuffner T; Tsai VW; Husaini Y; Wu L; Brown DA; Grewal T; Brown LJ; Curmi PM; Breit SN
    J Cell Sci; 2012 Nov; 125(Pt 22):5479-88. PubMed ID: 22956539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.